Molecular Oncology Committee

To coordinate and focus scientific resources involved in molecular testing and develop appropriate guidelines for the molecular pathology laboratory; to monitor emerging and future changes in cellular and molecular pathology to include practical applications of new modalities; to support state of the art practice of molecular diagnostics; to develop, maintain and enhance proficiency testing surveys and educational programs in the field of molecular pathology; and to advise on public policy as it applies to molecular pathology.

Charge

To advance the practice of Molecular Oncology diagnostics by:

Coordinating scientific resources involved in molecular diagnostics.
Monitoring the current state of the field and incorporating new modalities and clinical applications into laboratory practice.
Developing, maintaining, and enhancing clinically relevant proficiency testing and educational programs in the field of molecular oncology.
Disseminating proficiency performance data and supporting the development of evidence-based guidelines to promote laboratory excellence and quality patience care.
Reviewing and providing feedback on public policy as it applies to the practice of molecular pathology.

This committee reports to the Council on Scientific Affairs. View a list of the Current Committee Members and find additional resources and information in the Molecular Oncology Topic Center.

Commitment

Activities of Committee

Create and support state of the art Proficiency Testing Programs, through sample preparation, formulating a questionnaire, data review, and critique development.
Work with highly skilled Washington, DC, staff on regulatory issues.
Develop educational seminars and adjuncts for the CAP National Meetings.
Work in support of CAP Laboratory Accreditation Program requirements for molecular pathology and genetics.
Work on special projects (eg, research studies, manuscript summarizing our experience with proficiency surveys, or describing our practice recommendations).

Expertise or Experience

Working knowledge of molecular oncology practice, technology, and clinical applications
Strong interest in promoting molecular oncology
Ability to provide tools for the community pathologist to guide their practice of molecular pathology

Benefits of Committee Membership

Interact with colleagues on state of the art technology and practice issues
Gain knowledge about regulatory and financial aspects of pathology practice
Learn through research and educational projects
Share ideas and protocols with colleagues around the country

Representation on Committee Beyond the CAP

Two liaisons, one from Association for Molecular Pathology and one from American Association of Clinical Chemistry

Current Committee Members

Chair

Neal I Lindeman, MD, FCAP

Vice Chair

Rena Xian, MD, FCAP

Member

Leomar Y Ballester, MD, PhD, FCAP

David S Bosler, MD, FCAP

Noah Aaron Brown, MD, FCAP

Dhananjay Arun Chitale, MD, MBA, DABCC, FCAP

Georgios Deftereos, MD, FCAP

Yi Ding, MD, PhD, FCAP

Eric J Duncavage, MD, FCAP

Mark D Ewalt, MD, FCAP

Kevin E Fisher, MD, PhD, FCAP

Katherine B Geiersbach, MD, FCAP

Joanna A Gibson, MD, PhD, FCAP

Susan Hsiao, MD, PhD, FCAP

Richard Sheng Poe Huang, MD, FCAP

Ravindra Kolhe, MD, PhD, FCAP

Manando Nakasaki, MD, PhD, FCAP

Madhu Micheal Ouseph, MD, PhD, FCAP

Sinchita Roy Chowdhuri, MD, MBBS, PhD, FCAP

James Patrick Solomon, MD, PhD, FCAP

Tracy Stockley, PhD

Eric Vail, MD, FCAP

Abigail I Wald, PhD

Ying Wang, MD, PhD, FCAP

Venkata Yellapantula, PhD, MS

Ahmet Zehir, PhD

Linsheng Zhang, MD, PhD, FCAP

Member-J

Kyle Dyson, MD, PhD,

Trevor Killeen, MD,

Christina Su, MD, PhD,

Advisor

Eric Konnick, MD, MS, FCAP

Liaison - Inbound

Joel A Lefferts, PhD, HCLD, DABCC

Daniel E Sabath, MD, PhD,

Committee Manager

Megan Kane, MS, MLS(ASCP)cm